cardiovascular


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

cardiovascular

of or relating to the heart and the blood vessels

cardiovascular

[¦kärd·ē·ō′vas·kyə·lər]
(physiology)
Pertaining to the heart and circulatory system. Also known as cardiocirculatory.
References in periodicals archive ?
The adipose tissue also secretes factors that are implicated in inflammatory processes, blood pressure, coagulation and fibrinolysis that can influence the development of cardiovascular disease.
Robert Harrington, MD, Professor of Medicine and Director of Cardiovascular Clinical Trials at Duke Clinical Research Institute and Dr.
Because ultrasound enabled the researchers to gauge the cardiovascular health of each participant--rather than only of those who had suffered strokes and other cardiovascular ills--the new study is more powerful than previous attempts to determine arsenic's effect on arteries, says Allan H.
This means that instead of focusing on race so exclusively, we ought to be looking for whatever it is in the early experiences of these groups that influences later cardiovascular risk,'' Alderman said in a telephone interview.
Scope - The report provides cardiovascular devices market information broken down into detailed categories in Europe.
But estrogen-testosterone formulations are approved only for mood symptoms and hot flashes because of fears that testosterone might undo estrogen's cardiovascular benefits.
There are several, controllable risk factors associated with the development of cardiovascular disease.
This report offers insight into R&D trends in the cardiovascular market, including the discontinuation of key pipeline drugs such as Pfizer's torcetrapib and atorvastatin, and the development of new drug classes including Novartis' Rasilez (aliskiren), anticipated to be the first to market direct renin inhibitor.
a prominent cardiovascular pathologist who co-chairs the Scientific Advisory Board for the HRP Initiative added, "Coming together under the umbrella of the HRP Initiative to work collaboratively to move research and development of this important disease forward will improve diagnosis and treatment of patients at high risk for serious cardiovascular disease.
CHAPTER 3 ANALYSIS OF POTENTIAL FUTURE CARDIOVASCULAR BLOCKBUSTERS
Dr Benedict Broennimann, President and CEO of LCV, commented that: "The partnership deal illustrates that Leman Cardiovascular and Hancock Jaffe Laboratories have a recognized know-how in biological tissue treatment to develop new generations of implants that cardiovascular markets require.
This research examines the European Cardiovascular Market in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts and growth rates and strategic recommendations.

Full browser ?